Back to Agenda
IQVIA Innovation Theater: Modernizing Regulatory Evidence with Real World Studies
Session Chair(s)
Nancy A Dreyer, PhD, MPH, FISPE
Founder
Dreyer Strategies LLC, United States
Although RCTs may be the gold standard for approving new treatments, the results are not always generalizable to less idealized settings or more diverse patients. Real-world evidence (RWE) plays an important role in understanding how well a therapy works, for which patients, and under what conditions. In this session, we review the complementary nature of RCTs and RWE, discuss Friends of Cancer Research learnings, and reinforce the call for methods to guide reliable regulatory use of RWE.
Speaker(s)
Panelist
Jeff Allen, PhD
Friends of Cancer Research, United States
President and Chief Executive Officer
Panelist
Jennifer Christian, PharmD, PhD, MPH, FISPE
Target RWE, United States
Chief Scientific Officer
Have an account?